Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44


Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin Therapy.

Chiefari E, Capula C, Vero A, Oliverio R, Puccio L, Liguori R, Pullano V, Greco M, Foti D, Tirinato D, Vero R, Brunetti A.

Diabetes Technol Ther. 2015 Jul;17(7):468-74. doi: 10.1089/dia.2014.0412. Epub 2015 Apr 6.


A novel mechanism of post-translational modulation of HMGA functions by the histone chaperone nucleophosmin.

Arnoldo L, Sgarra R, Chiefari E, Iiritano S, Arcidiacono B, Pegoraro S, Pellarin I, Brunetti A, Manfioletti G.

Sci Rep. 2015 Feb 25;5:8552. doi: 10.1038/srep08552.


Cooperation between HMGA1, PDX-1, and MafA is Essential for Glucose-Induced Insulin Transcription in Pancreatic Beta Cells.

Arcidiacono B, Iiritano S, Chiefari E, Brunetti FS, Gu G, Foti DP, Brunetti A.

Front Endocrinol (Lausanne). 2015 Jan 13;5:237. doi: 10.3389/fendo.2014.00237. eCollection 2014.


Prevalence and predictors of postpartum glucose intolerance in Italian women with gestational diabetes mellitus.

Capula C, Chiefari E, Vero A, Foti DP, Brunetti A, Vero R.

Diabetes Res Clin Pract. 2014 Aug;105(2):223-30. doi: 10.1016/j.diabres.2014.05.008. Epub 2014 May 29.


Recent advances in the molecular genetics of type 2 diabetes mellitus.

Brunetti A, Chiefari E, Foti D.

World J Diabetes. 2014 Apr 15;5(2):128-40. doi: 10.4239/wjd.v5.i2.128. Review.


Early effects of a hypocaloric, Mediterranean diet on laboratory parameters in obese individuals.

Greco M, Chiefari E, Montalcini T, Accattato F, Costanzo FS, Pujia A, Foti D, Brunetti A, Gulletta E.

Mediators Inflamm. 2014;2014:750860. doi: 10.1155/2014/750860. Epub 2014 Mar 4.


Transcriptional regulation of the HMGA1 gene by octamer-binding proteins Oct-1 and Oct-2.

Chiefari E, Arcidiacono B, Possidente K, Iiritano S, Ventura V, Pandolfo R, Brunetti FS, Greco M, Foti D, Brunetti A.

PLoS One. 2013 Dec 18;8(12):e83969. doi: 10.1371/journal.pone.0083969. eCollection 2013.


Evidence that an HMGA1 gene variant associates with type 2 diabetes, body mass index, and high-density lipoprotein cholesterol in a Hispanic-American population.

Pullinger CR, Goldfine ID, Tanyolaç S, Movsesyan I, Faynboym M, Durlach V, Chiefari E, Foti DP, Frost PH, Malloy MJ, Brunetti A, Kane JP.

Metab Syndr Relat Disord. 2014 Feb;12(1):25-30. doi: 10.1089/met.2013.0086. Epub 2013 Oct 22.


Gestational diabetes mellitus: screening and outcomes in southern italian pregnant women.

Capula C, Chiefari E, Vero A, Arcidiacono B, Iiritano S, Puccio L, Pullano V, Foti DP, Brunetti A, Vero R.

ISRN Endocrinol. 2013 Sep 5;2013:387495. doi: 10.1155/2013/387495. eCollection 2013.


Predictors of postpartum glucose tolerance testing in italian women with gestational diabetes mellitus.

Capula C, Chiefari E, Vero A, Iiritano S, Arcidiacono B, Puccio L, Pullano V, Foti D, Brunetti A, Vero R.

ISRN Endocrinol. 2013 Jul 17;2013:182505. doi: 10.1155/2013/182505. eCollection 2013.


A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components.

Chiefari E, Tanyolaç S, Iiritano S, Sciacqua A, Capula C, Arcidiacono B, Nocera A, Possidente K, Baudi F, Ventura V, Brunetti G, Brunetti FS, Vero R, Maio R, Greco M, Pavia M, Hodoglugil U, Durlach V, Pullinger CR, Goldfine ID, Perticone F, Foti D, Brunetti A.

Sci Rep. 2013;3:1491. doi: 10.1038/srep01491.


Functional relationship between high mobility group A1 (HMGA1) protein and insulin-like growth factor-binding protein 3 (IGFBP-3) in human chondrocytes.

Gasparini G, De Gori M, Paonessa F, Chiefari E, Brunetti A, Galasso O.

Arthritis Res Ther. 2012 Oct 4;14(5):R207. doi: 10.1186/ar4045.


The HMGA1-IGF-I/IGFBP system: a novel pathway for modulating glucose uptake.

Iiritano S, Chiefari E, Ventura V, Arcidiacono B, Possidente K, Nocera A, Nevolo MT, Fedele M, Greco A, Greco M, Brunetti G, Fusco A, Foti D, Brunetti A.

Mol Endocrinol. 2012 Sep;26(9):1578-89. doi: 10.1210/me.2011-1379. Epub 2012 Jun 28.


Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms.

Arcidiacono B, Iiritano S, Nocera A, Possidente K, Nevolo MT, Ventura V, Foti D, Chiefari E, Brunetti A.

Exp Diabetes Res. 2012;2012:789174. doi: 10.1155/2012/789174. Epub 2012 Jun 4. Review.


Comment on: Marquez et al. Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes 2012;61:524-530.

Brunetti A, Chiefari E, Pullinger CR, Tanyolac S, Foti D, Durlach V, Goldfine ID.

Diabetes. 2012 May;61(5):e3. doi: 10.2337/db12-0051. No abstract available.


HMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway.

Chiefari E, Nevolo MT, Arcidiacono B, Maurizio E, Nocera A, Iiritano S, Sgarra R, Possidente K, Palmieri C, Paonessa F, Brunetti G, Manfioletti G, Foti D, Brunetti A.

Sci Rep. 2012;2:251. doi: 10.1038/srep00251. Epub 2012 Feb 7.


[Perspectives on the contribution of genetics to the pathogenesis of type 2 diabetes mellitus].

Brunetti A, Chiefari E, Foti D.

Recenti Prog Med. 2011 Dec;102(12):468-75. doi: 10.1701/998.10858. Italian.


Functional variants of the HMGA1 gene and type 2 diabetes mellitus.

Chiefari E, Tanyolaç S, Paonessa F, Pullinger CR, Capula C, Iiritano S, Mazza T, Forlin M, Fusco A, Durlach V, Durlach A, Malloy MJ, Kane JP, Heiner SW, Filocamo M, Foti DP, Goldfine ID, Brunetti A.

JAMA. 2011 Mar 2;305(9):903-12. doi: 10.1001/jama.2011.207.


Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes.

Chiefari E, Iiritano S, Paonessa F, Le Pera I, Arcidiacono B, Filocamo M, Foti D, Liebhaber SA, Brunetti A.

Nat Commun. 2010 Jul 27;1:40. doi: 10.1038/ncomms1040.


New target genes for the peroxisome proliferator-activated receptor-γ (PPARγ) antitumour activity: Perspectives from the insulin receptor.

Foti DP, Paonessa F, Chiefari E, Brunetti A.

PPAR Res. 2009;2009:571365. doi: 10.1155/2009/571365. Epub 2009 Jun 29.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk